LABORATORY NEWS
-
Labcorp To Offer First FDA-Cleared Blood Test To Rule out Alzheimer's-Related Amyloid Pathology In Primary Care Settings
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood test cleared by the U.S. Food and Drug Administration (FDA) to aid in the initial assessment for Alzheimer's disease and other causes of cognitive decline in the primary-care setting.
- Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement To Develop Droplet Digital™ PCR High Complexity Assays
- Aiforia Signs A Local Agreement With Siemens Healthineers Finland
- OncoHost Receives New York State Laboratory Permit, Expanding Availability Of PROphetNSCLC® Precision Oncology Test
- Diasorin Signs A Supplier Agreement With Quest Diagnostics For The Innovative Molecular Multiplexing Platform, LIAISON PLEX
ARCHIVED NEWSLETTER
- 10.21.25 -- Automation In The Lab: Lessons From Successes And Setbacks
- 10.07.25 -- Unpacking Pfizer's Advanced Process Control Platform For Upstream Ops
- 09.23.25 -- Weight Of Evidence Assessments For Carcinogenicity Studies: An Overview
- 09.09.25 -- Nearly 40% Of Biomanufacturers Eyeing Continuous Processing
- 08.26.25 -- Environmental Monitoring Performance Qualification In New Drug Manufacturing Facilities